Bone mineral density in juvenile dermatomyositis: Assessment using dual x-ray absorptiometry

Arthritis and Rheumatism

Volumn 48, Issue 8, 2003, Pages 2294-2298

  Stewart, W A ^a   Acott, P D ^a   Salisbury, S R ^a   Lang, B A ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PAMIDRONIC ACID;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MINERAL; CHILD; CLINICAL ARTICLE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DISEASE ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INFLAMMATORY DISEASE; LUMBAR SPINE; MALE; MUSCLE WEAKNESS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; DENSITOMETRY, X-RAY; DERMATOMYOSITIS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUMBAR VERTEBRAE; MALE; RISK FACTORS; SPINAL FRACTURES;

EID: 0042072942     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11211     Document Type: Article

References (15)

1. Sullivan DB, Cassidy JT, Petty RE. Dermatomyositis in the pediatric patient. Arthritis Rheum 1977;20 Suppl:327-31.
2. Perez MD, Abrams SA, Koenning G, Stuff JE, O'Brien KO, Ellis KJ. Mineral metabolism in children with dermatomyositis. J Rheumatol 1994;21:2364-9.
3. Cassidy JT, Petty RE. Textbook of pediatric rheumatology. Philadelphia: WB Saunders; 2001.
4. Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996;11:707-30.
5. Hopp R, Degan J, Gallagher JC, Cassidy JT. Estimation of bone mineral density in children with juvenile rheumatoid arthritis. J Rheumatol 1991;18:1235-9.
6. Reed A, Haugen M, Pachman LM, Langman CB. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr 1990;116:574-80.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
8. Malleson PN. Controversies in juvenile dermatomyositis. J Rheumatol Suppl 1990;22:1-2 and 3-6.
9. Faulkner RA, Bailey DA, Drinkwater DT, McKay HA, Arnold C, Wilkinson AA. Bone densitometry in Canadian children 8-17 years of age. Calcif Tissue Int 1996;59:344-51.
10. Johnston CC Jr, Slemenda CW, Melton LJ III. Clinical use of bone densitometry. N Engl J Med 1991;324:1105-9.
11. Kanis JA for the WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994;4:368-81.
12. Henderson CJ, Cawkwell GD, Specker BL, Sierra RI, Wilmott RW, Campaigne BN, et al. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40:1967-75.
13. Bianchi ML, Cimaz R, Bardare M, Zulian F, Lepore L, Boncompagni A, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 2000;43:1960-6.
14. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992;75:1060-5.
15. Haugen M, Lien G, Flatø B, Kvammen J, Vinje O, Sørskaar D, et al. Young adults with juvenile arthritis in remission attain normal peak bone mass at the lumbar spine and forearm. Arthritis Rheum 2000;43:1504-10.